Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 12, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.49 $77.19
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 12

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,572

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 12, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.49 $161.85
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 12

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,596

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 12, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.49 $261.45
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 12

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,335

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 11, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.48 $49.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 11

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,508

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 11, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.48 $76.88
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 11

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,541

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 11, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.48 $161.20
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 11

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,531

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 11, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.48 $260.40
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 11

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,230

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 10, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.53 $50.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 10

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,488

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 10, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.53 $78.43
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 10

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,510

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 10, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.53 $164.45
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 10

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,466

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 10, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.53 $265.65
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 10

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,125

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 07, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.66 $53.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 9

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,468

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 07, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.66 $82.46
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 9

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,479

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 07, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.66 $172.90
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 9

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,401

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 07, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.66 $279.30
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 9

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,020

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 06, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.65 $53.00
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 8

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,448

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 06, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.65 $82.15
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 8

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,448

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 06, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.65 $172.25
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 8

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,336

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 06, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.65 $278.25
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 8

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,915

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 05, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.58 $51.60
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 7

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,428

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 05, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.58 $79.98
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 7

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,417

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 05, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.58 $167.70
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 7

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,271

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 05, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.58 $270.90
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 7

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,810

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 04, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.61 $52.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 6

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,408

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 04, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.61 $80.91
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 6

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,386

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 04, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.61 $169.65
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 6

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,206

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 04, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.61 $274.05
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 6

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,705

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 03, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.54 $50.80
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 5

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,388

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 03, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.54 $78.74
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 5

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,355

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 03, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.54 $165.10
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 5

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,141

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
October 03, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.54 $266.70
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 5

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,600

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 30, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.61 $52.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 4

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,368

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 30, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.61 $80.91
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 4

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,324

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 30, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.61 $169.65
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,076

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 30, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.61 $274.05
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 4

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,495

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 29, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.51 $50.20
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 3

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,348

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 29, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.51 $77.81
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 3

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,293

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 29, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.51 $163.15
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 3

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,011

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 29, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.51 $263.55
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 3

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,390

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 28, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.52 $50.40
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 2

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,328

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 28, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.52 $78.12
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 2

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,262

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 28, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.52 $163.80
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 2

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,946

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 28, 2022 Filed Nov 18, 2022 22:16 UTC PurchaseCommon Stock 105 $2.52 $264.60
Disclosure

SEC source: 0001209191-22-057939 · doc4.xml · nonDerivative · entry 2

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,285

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Sep 30, 2022 21:17 UTC PurchaseCommon Stock 20 $2.57 $51.40
Disclosure

SEC source: 0001209191-22-051671 · doc4.xml · nonDerivative · entry 30

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,308

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Sep 30, 2022 21:15 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.57 $79.67
Disclosure

SEC source: 0001209191-22-051669 · doc4.xml · nonDerivative · entry 30

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,231

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Sep 30, 2022 21:13 UTC PurchaseCommon Stock 65 $2.57 $167.05
Disclosure

SEC source: 0001209191-22-051667 · doc4.xml · nonDerivative · entry 30

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,881

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 105 $2.57 $269.85
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 30

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,180

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Nov 18, 2022 22:23 UTC PurchaseCommon Stock 20 $2.57 $51.40
Disclosure

SEC source: 0001209191-22-057947 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,308

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Nov 18, 2022 22:21 UTC
Jones JamesDirector
PurchaseCommon Stock 31 $2.57 $79.67
Disclosure

SEC source: 0001209191-22-057945 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,231

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
September 27, 2022 Filed Nov 18, 2022 22:17 UTC PurchaseCommon Stock 65 $2.57 $167.05
Disclosure

SEC source: 0001209191-22-057942 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,881

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.